FdaApplication
NDA 206627
Identifiers
- fda_app_no: NDA206627
Properties
| Property | Value |
|---|---|
| applicant_name | KNOA PHARMA LLC |
| application_type | NDA |
| approval_date | 2014-11-20 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYSINGLA ER | HYDROCODONE BITARTRATE | 40MG | TABLET, EXTENDED RELEASE;ORAL |
| HYSINGLA ER | HYDROCODONE BITARTRATE | 120MG | TABLET, EXTENDED RELEASE;ORAL |
| HYSINGLA ER | HYDROCODONE BITARTRATE | 60MG | TABLET, EXTENDED RELEASE;ORAL |
| HYSINGLA ER | HYDROCODONE BITARTRATE | 80MG | TABLET, EXTENDED RELEASE;ORAL |
| HYSINGLA ER | HYDROCODONE BITARTRATE | 30MG | TABLET, EXTENDED RELEASE;ORAL |
| HYSINGLA ER | HYDROCODONE BITARTRATE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| HYSINGLA ER | HYDROCODONE BITARTRATE | 20MG | TABLET, EXTENDED RELEASE;ORAL |
7 products